ARCHIVES

NCI Eases Some Cooperative Group Concern; DeVita Considers Other CCOP- Research Base Funding Option

This article is from The Cancer Letter archive.

Vol. 08 No. 14 | April 2, 1982

Download PDF Visit The Full Archive

Related Articles

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made

March 2, 1984

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

Holland, Hoogstraten Give Up Chairmanships Of CALGB, SWOG

March 6, 1981

New Drug Combination Shrinks Kidney Cancers

June 30, 2006